Background: Glycosylated hemoglobin, HbA 1c is the most acceptable measure of chronic glycemia. It is not widely available and/or affordable in Nigeria. The mean of the monthly fasting plasma glucose (MFPG) of the preceding 3 months is often used as surrogate for assessing chronic glycemia. Objective: To determine the relationships among fasting plasma glucose (FPG), 2-hour post-prandial glucose (2-hPG), HbA1c, and MFPG. Materials and Methods: Hospital records were used to derive the MFPGs of diabetic subjects from the mean of their monthly FPGs of the preceding three months. Other data extracted included the patient's age, sex, body mass index (BMI), waist circumference (WC), and duration of diabetes mellitus (DMDU). FPG, 2-hPG and HbA 1c were determined during this index consultation. Results: Ninety five persons (65 males, 30 females) with type 2 were included in the study. Their mean age and DMDU were 54.7 ± 8.9 years and 8.1 ± 6.1 years, respectively. Their mean WC, BMI, FPG, 2-hPG, HbA1c, and MFPG were 100.2 ± 11.0 cm, 24.2 ± 4.3 kgm/2, 7.5 ± 2.4 mmol/l, 10.4 ± 4.1 mmol/l, 8.2 ± 2.2%, and 5.9 ± 2.2 mmol/l, respectively. The males were significantly older (57.5 ± 8.4 vs 49.3 ± 7.6, P<0.001) while the females had higher waist circumference and BMI than their male counterparts: 104.8 ± 11.6 cm vs 92.8 ± 10.1 cm, P<0.004; and 25.8 ± 4.9 kg/m 2 vs 23.3 ± 3.7 kg/m 2 , P<0.005, respectively. There were no significant differences in FPG, 2-hPG, MFPG and HbA1c levels between male and female subjects. There were significant positive correlations between FPG and HbA1c (r=0.45, P=0.05) and between 2-hPG and HbA1c (r=0.52, P=0.01), but there was no positive correlation between MFPG and HbA1c (r=−0.20, P=0.18). Conclusion: There is no positive correlation between MFPG and HbA 1c and thus MFPG may not be a good surrogate for HbA1c in assessment of chronic glycemia in our patients.
Introduction
Hemoglobin A 1c is formed from irreversible glycosylation of erythrocyte hemoglobin in proportion to circulating plasma levels of glucose. [1, 2] HbA 1c level provides an index of the average blood glucose concentration over the previous 2-3 months. [3] [4] [5] Presently, HbA 1c is the most acceptable and widely used measure of chronic glycemia. [2] Elevated HbA 1c levels have been associated with long-term complications of diabetes mellitus. [6, 7] Its level is therefore used to determine whether treatment is adequate. Many Nigerians with diabetes mellitus do not achieve good long term glycemic control when HbA 1c is used as an index of chronic glycemia.
Relationships between hemoglobin A 1c and spot glucose measurements in Nigerians with type 2 diabetes mellitus
Idogun and Olumese [8] reported that only 53% of 64 type 2 diabetic patients seen in a tertiary medical centre in Benin City had good glycemic control. Adebisi et al., [9] found only 36% of diabetic patients had HbA 1c ≤7.2% in Ilorin.
Unfortunately HbA 1c is not widely available and/or affordable in most hospitals in Africa, [10] Nigeria inclusive. In Nigeria, the mean of the three most recent fasting plasma glucose (MFPG) results documented in the patient's last three hospital consultations is often calculated and used as surrogate for long term glycemia in place of HbA 1c . However, it is not known with certainty if there is a strong correlation between the calculated mean fasting plasma glucose (MFPG) and HbA 1c in Nigerians with type 2 diabetes mellitus. This study is to determine the relationship among HbA 1c , fasting plasma glucose, 2-h post-prandial plasma glucose and the mean of the last three FPG levels of Nigerians with type 2 diabetes mellitus with a view to determining the suitability or otherwise of using MFPG as a surrogate for HbA 1c .
Materials and Methods
Hospital records of all patients with type 2 DM seen at the diabetes clinic over a 3-month period were retrieved for the study. Data documented included the patient's age, sex, body mass index (BMI), waist circumference (WC), and duration of diabetes mellitus. All consenting patients with type 2 diabetes mellitus were educated about the aim of the study and were instructed to come to the Diabetes Clinic fasting on test days.
On arrival at the Diabetes Clinic in the morning, blood samples were drawn for determination of FPG (after 8-10 hour overnight fast) and HbA 1c . After which subjects drank within 5 minutes a glucose solution prepared by dissolving 75 g anhydrous glucose in 250 ml of water. Two hours later, blood samples were drawn to determine the 2-h postprandial plasma glucose (2-hPG). The mean fasting plasma glucose (MFPG) values was derived from the mean of the monthly FPG of the preceding three months documented in the patient's hospital record.
Plasma glucose was determined by the glucose oxidase method of Trinder. [11] HbA 1c level was determined with an automated HbA 1c point-of-care-testing analyser, the Bio-Rad in2it (Bio-Rad Laboratories Deeside, CH5 2NU, UK) using a drop of blood obtained by finger prick.
All the study subjects voluntarily gave informed consent. The Hospital Ethics and Research Committee approved the study.
Exclusion criteria
All pregnant subjects with type 2 diabetes mellitus, all type 1 DM patients, all type 2 DM subjects who were unwilling to give consent for the study, those who were ill, and any subject who could not complete every aspect of the study were excluded.
Definition of terms
Good long term glycaemic control was defined according to the American Diabetes Association criteria [12] as a HbA 1c <7%. Otieno et al., [13] reported that the morning random blood glucose (RBS) level had a linear relationship with glycated hemoglobin taken simultaneously when the RBS is less than 10 mmol/l. Gill et al., [14] documented a positive correlation between RBS and HbA 1c (r=0.54). Further study is desirable to validate this in our locale.
Statistical analysis
The mean of the monthly fasting plasma glucose (MFPG) of the last three months was within acceptable target glycemic levels in our study. This gives a false sense of a good long-term glycemic control whereas the HbA 1c clearly showed that a majority (63%) of our patients had poor long term glycemic control as evidenced by values of HbA 1c >7.0%. Our patients are generally not adherent to diet and anti-diabetic drugs. They tend to maintain better glycemia immediately before and after the consultation. This is, however, not substained on a long-term basis.
The correlation between FPG and HbA 1c (r=0.45) and between 2-h postprandial glucose and HbA 1c (r=0.52) found in this study were smaller than those of r=0.71 and r=0.79 for FPG vs HbA 1c and 2hPG vs HbA 1c , respectively, documented by Van-'t Riet et al., [15] in patients with diabetes mellitus in a Dutch population. Nathan et al., [4] also reported that HbA 1c correlated closely with a complete measure of average glycemia over the preceding 8-12 weeks. Nathan and colleagues measured mean glucose levels by continuous glucose monitoring, which measured interstitial glucose levels every 5 min, for 12 weeks. A strong correlation between mean blood glucose and HbA 1c in type 2 diabetes mellitus was also documented by Makris et al., [5] among Greek patients with type 2 diabetes (r=0.92). In the Greek study, mean blood glucose was calculated for each patient from self measurements of blood glucose using a portable glucometer, made six times a day (before eating and 2 h after a meal), three times a week for 1 month.
There was, however, no positive correlation between the MFPG and HbA 1c in our patients compared to those documented in Caucasians. In the Caucasian studies, mean blood glucose were determined by continuous blood glucose monitoring every 5 min, for 12 weeks by Nathan et al., [4] six times a day, three times a week in the Makris et al., [5] compared to the once-a-month FPG in our study. The mean of the glucose level from the continuous glucose monitoring is expectedly more likely to correlate with HbA 1c. This is due to less day-to-day variability of fasting plasma glucose in diabetic patients when plasma fasting glucose is done on a daily basis [16] rather than it being done once a month.
In our study, 2hPG had a stronger correlation with HbA 1c than FPG as in previous studies. [17, 18] In an analysis of glucose profiles and HbA 1c in the Diabetes Control and Complication Trial, Rohlfing et al., [17] found that among individual time points, afternoon and evening plasma glucose (post lunch, pre-dinner, post-dinner, and bedtime) showed higher correlations with HbA 1c than the morning time points (pre-breakfast, post-breakfast, and pre-lunch). This finding is similar to that of Woerle et al., [18] who noted that both FPG and 2-hPG levels increased as HbA 1c increased but that 2-hPG level increased at a rate 4 times greater than FPG and accounted for a greater proportion of HbA 1c .
Our patient characteristics such as age, gender and BMI were not associated with adequate glycaemic control. This observation was previously reported by Goudswaard et al., [19] and was recently reaffirmed by Rätsep et al. [20] In conclusion, MFPG derived from the mean of the monthly FPG done over the preceding 3 months in our patients with type 2 diabetes mellitus did not correlate positively with HbA 1c and thus may not be a good surrogate for HbA 1c as a measure of long-term glycemic control. FPG and 2-hPG both showed linear relationship with HbA 1c ; however, a larger scale study is needed to determine their usefulness as possible predictors of long term glycemic control in resource-constraint environment. It is thus recommended that further studies involving patients who do their FPG weekly at least for 12 weeks should be done to assess if that will give a better correlation with HbA 1c as continuous glucose monitoring is not feasible in our environment.
Limitation of study
The sample size is rather small due to the high cost of HbA 1c and the difficulty in getting subjects with diabetes mellitus to participate in research in our practice locale. 
